tiprankstipranks
Springworks Therapeutics (SWTX)
NASDAQ:SWTX
US Market

Springworks Therapeutics (SWTX) Financial Statements

307 Followers

Springworks Therapeutics Financial Overview

Springworks Therapeutics's market cap is currently ―. The company's EPS TTM is $-4.986; its P/E ratio is -8.31; Springworks Therapeutics is scheduled to report earnings on July 31, 2024, and the estimated EPS forecast is $-1.12. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 5.45M----
Gross Profit$ 5.03M----
EBIT-$ -79.44M$ -77.92M$ -73.42M$ -78.98M
EBITDA--$ -77.54M$ -73.17M-
Net Income Common Stockholders$ -94.32M$ -79.44M$ -77.92M$ -73.42M$ -74.18M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 479.25M$ 422.42M$ 476.71M$ 528.14M$ 592.22M
Total Assets$ 725.79M$ 467.65M$ 517.33M$ 569.20M$ 616.68M
Total Debt$ 7.06M$ 7.33M$ 7.61M$ 7.05M$ 5.25M
Net Debt$ -472.19M$ -415.09M$ -469.10M$ -521.09M$ -586.97M
Total Liabilities$ 99.57M$ 72.75M$ 65.89M$ 62.27M$ 630.27M
Stockholders Equity$ 626.22M$ 394.90M$ 451.42M$ 506.92M$ 558.22M
Cash Flow-
Free Cash Flow--$ -50.90M$ -64.80M$ -55.96M
Operating Cash Flow$ -62.70M$ -50.46M$ -47.81M$ -61.82M$ -54.20M
Investing Cash Flow$ -159.21M$ 34.60M$ 60.76M$ 98.60M$ -355.01M
Financing Cash Flow$ 299.07M$ -242.00K$ -342.00K$ -1.85M$ -339.77M
Currency in USD

Springworks Therapeutics Earnings and Revenue History

Springworks Therapeutics Debt to Assets

Springworks Therapeutics Cash Flow

Springworks Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis